BioMedNewsBreaks – Exciting Opportunity for Clinical Quality Professionals Coming in Fall 2020

Clinical Document World promises to be the year’s learning and networking event for life science professionals. The virtual event, produced by Lincoln Health Network and slated to take place from Sept. 15-18, 2020, is designed to enhance attendees’ clinical trial document process in order to have a complete Trial Master File (“TMF”) as well as enable their businesses to improve clinical quality, implement new technology and be inspection ready. Clinical Document World offers over 45 educational sessions that cover all aspects of clinical document management, including regulatory guidance, compliance, quality, and technology. Ideal attendees are life science professionals from pharmaceutical, biotech and medical device organizations with responsibilities in clinical documentation, TMF, inspection readiness, clinical operations, and others. Over 40 industry leaders with expertise in clinical operations, TMF, quality, technology, and inspections will share insight and discuss advancements and innovations to implement and deploy for enhanced document management.

To view the full press release, visit http://ibn.fm/4bOub

About Lincoln Health Network

Lincoln Health Network is the pharmaceutical, medical devices, and life science go-to source for thought leadership and industry news. Research is driven through industry case studies – providing actionable data, benchmarking and insights into leading programs. Along with leading regulatory and compliance information, Lincoln Health Network’s events provide a dynamic platform for professionals to gain new education, expand networks and drive business results. Each conference, summit and workshop connects decision makers with networking, technology solutions and cutting-edge, peer-driven content. To learn more, visit www.LincolnHealthNetwork.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Oncotelic Therapeutics Inc. (OTLC) Venture Begins Clinical Trials of Innovative Cancer Therapy

Oncotelic Therapeutics (OTCQB: OTLC) venture Sapu Nano recently secured approval from Australia’s Human Research Ethics Committee…

10 hours ago

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Highlights Key Clinical Progress and Reports Q3 2025 Financial Results 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company advancing treatments for rare diseases with unmet medical…

15 hours ago

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Sets Nov. 13 Webcast to Review Q3 2025 Results and AI Platform Developments

  Lantern Pharma (NASDAQ: LTRN), an AI-driven company developing targeted cancer therapies through its proprietary…

2 days ago

BioMedNewsBreaks — NextPlat Corp. (NASDAQ: NXPL, NXPLW) Subsidiary PharmcoRx Awarded Multi-State Prescription Fulfillment Contract From DevotedDOc 

NextPlat (NASDAQ: NXPL, NXPLW), a global provider of healthcare and technology solutions through e-commerce and…

3 days ago

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Initiated With Buy Rating and $4 Price Target by Roth Capital

HeartBeam (NASDAQ: BEAT) has been initiated with a Buy rating and $4 price target by…

3 days ago

BioMedNewsBreaks — NextPlat Corp. (NASDAQ: NXPL, NXPLW) to Announce Q3 2025 Financial Results on Nov. 13 

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…

4 days ago